USD10
AQST delen
Info over Aquestive TherapeuticsAquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
USD10
AQST delen
Info over Aquestive TherapeuticsAquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Statistieken
HANDELSVENSTER
Gesloten
OPENT OM
Onvoldoende gegevens
MARKTKAPITALISATIE
US$ 495,50 mln.
OPENINGSPRIJS
US$ 4,04
LAAG (1J)
US$ 2,12
HOOG (1J)
US$ 7,55
LAAG (24u)
US$ 3,96
HOOG (24H)
US$ 4,14
VOLUME (24 uur)
US$ 2,66 mln.
26,02%
Prijsgeschiedenis
Time | Price | Change |
|---|---|---|
Vandaag | US$ 4,04 | |
1 dag | US$ 3,98 | |
1 week | US$ 4,06 | 0,00% |
1 maand | US$ 3,95 | |
1 jaar | US$ 3,25 |